Sureguard LLC, a leading provider of proactive laboratory services, is actively seeking $11 million in funding to accelerate its mission of transforming patient care and outcomes in the long-term care industry. By addressing the shortcomings of reactive lab testing and outdated practices, Sureguard aims to maximize health, safety, and longevity for elderly residents in assisted living facilities.
The long-term care sector faces significant challenges, with preventable incidents often putting elderly residents at risk. Respiratory failure and urinary tract infections (UTIs) are leading causes of death in these facilities, while falls contribute to a high number of injury-related deaths and hospitalizations among older adults. Sureguard aims to combat these issues through innovative solutions and a proactive approach.
Sureguard's cutting-edge diagnostic tests, top laboratories, custom software, and skilled clinical operations team form the foundation of its approach. By implementing proactive programs for in-house residents, Sureguard aims to prevent falls, misdiagnoses, and fatal outcomes.
"We are dedicated to revolutionizing laboratory services in the long-term care industry and providing early intervention to prevent 90% of issues," says Jake Parrick, CEO of Sureguard. "Our goal is to safeguard the health and well-being of elderly residents and improve their quality of life."
To support its ambitious plans, Sureguard is actively seeking $5 to $11 million in funding through a SAFE (Simple Agreement for Future Equity) note. The raised funds will be allocated towards an 18-month runway, expanding the company's staff, increasing marketing spend, and acquiring valuable intellectual property. This funding will be instrumental in further strengthening Sureguard's position in the market and accelerating its mission to transform laboratory services.
Sureguard has already made substantial progress in forging partnerships with assisted living facilities. Since March, the company has secured agreements with 2,500 residents, reflecting the growing demand for proactive laboratory services. The estimated recurring annual value of these partnerships amounts to an impressive $13.8 million. With a strong pipeline, Sureguard aims to sign an additional 2,500 residents by the end of July, reaching a total estimated pipeline value of $27.6 million in annual recurring revenue.
Sureguard's commitment to excellence extends to its partnerships with top laboratories across the United States, ensuring access to state-of-the-art diagnostic testing. Moreover, long-term care facilities can benefit from Sureguard's services at no cost, while the company generates revenue through insurance reimbursements for testing.
As Sureguard embarks on its fundraising journey, the company invites potential investors to join in its mission of revolutionizing laboratory services and improving the lives of elderly residents. Interested investors can learn more about Sureguard and its vision by visiting their website or contacting the company directly.
Media Contact
Company Name: Sureguard LLC
Contact Person: Lee Brochstein
Email: Send Email
Phone: 713-703-8642
Country: United States
Website: https://sureguard.us
